Novo Holdings plans to double its newly acquired contract drugmaker, Catalent, within five years, focusing on U.S. manufacturing. The $16.5 billion acquisition is aimed at enhancing supply chains amid ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...

Ozempic, Zepbound, Wegovy, and other GLP-1 medications have transformed the way we lose weight. People who take them report life-changi ...